Subscribe or Manage Preferences

The following clinical trials represent a selection of key studies that are currently recruiting patients with lupus for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease.

The following clinical trials represent a selection of key studies that are currently recruiting patients with rheumatoid arthritis for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease.

The following clinical trials represent a selection of key studies that are currently recruiting patients with fibromyalgia for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease.

The following clinical trials represent a selection of key studies that are currently recruiting patients with osteoarthritis for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease.

The following clinical trials represent a selection of key studies that are currently recruiting patients with psoriatic arthritis for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease.

The following clinical trials represent a selection of key studies that are currently recruiting patients with scleroderma for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help rheumatology practice managers and providers direct their eligible patients to one of these clinical trials.
The following clinical trials represent a selection of key studies that are currently recruiting patients with lupus for inclusion in investigations of new therapies and new regimens of existing treatments for individuals with the disease. Each clinical trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help rheumatology practice managers and providers direct their eligible patients to one of these clinical trials.

The following clinical trials represent a selection of key studies that are currently recruiting patients with prostate cancer for investigations of new treatments or new combinations for patients with prostate cancer. Each clinical trial description includes the NLM Identifier used by ClinicalTrials.gov. The information below can help urologists direct their eligible patients to one of these studies.

The following clinical trials represent a selection of key clinical trials that are currently recruiting patients with juvenile idiopathic arthritis (JIA) for inclusion in investigations of new therapies and new regimens of available therapies for patients with JIA. Each trial description includes the NLM Identifier to be used as a reference with ClinicalTrials.gov. The information below can help rheumatology practice managers and providers direct their eligible patients to one of these trials.
The following clinical trials represent a selection of key clinical trials that are currently recruiting patients with gout for inclusion in investigations of new therapies and regimens of available therapies for patients with gout. Each clinical trial description includes the NLM Identifier to be used as a reference for Clin icalTrials.gov. The information below can help rheumatology practice managers and providers direct their eligible patients to one of these clinical trials.
Page 1 of 4
Results 1 - 10 of 40
  • American Health and Drug Benefits
  • Lynx CME
  • Value Based Care in Rheumatology
  • Oncology Practice Management
  • Urology Practice Management

Search